Abercrombie (ANF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Phathom Pharmaceuticals (PHAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The Q3 earnings season is slowly grinding to a halt, with just a small chunk of S&P 500 companies yet to reveal their ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Researchers trained computer models to predict everyday events, revealing that responding to uncertainty, rather than just ...

Tuesday, November 19, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly ...

Nvidia's 4.9 percent climb accounted for the vast majority of the turnaround. The chip company's stock rallied ahead of its ...

The creator and licensor of audio, video and voice technologies posted revenue of $304.8 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $305.8 million. For ...

SAO PAULO (AP) — SAO PAULO (AP) — XP Inc.A (XP) on Tuesday reported profit of $213.9 million in its third quarter. On a per-share basis, the Sao Paulo-based company said it had profit of 39 cents. The ...

Disney (DIS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for ...

Olo (OLO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HEICO makes a strong case for investment in the aerospace-defense equipment industry, given its solid growth prospects, ...